Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
When a patient's Hodgkin's lymphoma does not respond to primary treatment or returns, a stem cell transplant is recommended. Stanford has a highly established transplant program performing over 200 procedures every year. We have pioneered the use of less toxic conditioning regimens and clinical trials incorporating novel therapies with bone marrow transplantation.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.